Search Results - "KNATTERUD, G"

Presenting characteristics as predictors of duration of treatment in sarcoidosis by BAUGHMAN, R. P, JUDSON, M. A, TEIRSTEIN, A, YEAGER, H, ROSSMAN, M, KNATTERUD, G. L, THOMPSON, B

“…Some sarcoidosis patients never need therapy, but many still require therapy more than 2 years after initial diagnosis. To determine what features at initial…”
Get full text

Sarcoidosis: social predictors of severity at presentation by Rabin, D.L, Thompson, B, Brown, K.M, Judson, M.A, Huang, X, Lackland, D.T, Knatterud, G.L, Yeager, H., Jr, Rose, C, Steimel, J, on behalf of ACCESS Research Group

“…To determine relationships among social predictors and sarcoidosis severity at presentation, demographic characteristics, socioeconomic status, and barriers to…”
Get full text

Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18 by Davis, MD, Fisher, MR, Gangnon, RE, Barton, F, Aiello, LM, Chew, EY, Ferris, FL, 3rd, Knatterud, GL

“…To identify risk factors for the development of high-risk proliferative diabetic retinopathy (PDR) and for the development of severe visual loss or vitrectomy…”
Get full text

Asymptomatic cardiac ischemia pilot (ACIP) study two-year follow-up : Outcomes of patients randomized to initial strategies of medical therapy versus revascularization by DAVIES, R. F, GOLDBERG, A. D, FORMAN, S, PEPINE, C. J, KNATTERUD, G. L, GELLER, N, SOPKO, G, PRATT, C, DEANFIELD, J, CONTI, C. R

“…Patients with ischemia during stress testing and ambulatory ECG monitoring have an increased risk of cardiac events, but it is not known whether their…”
Get full text

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial : a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction by ANDERSON, H. V, CANNON, C. P, STONE, P. H, WILLIAMS, D. O, MCCABE, C. H, KNATTERUD, G. L, THOMPSON, B, WILLERSON, J. T, BRAUNWALD, E

“…We report mortality, infarction, revascularization and repeat hospital admission events for 1 year after enrollment and randomization in the Thrombolysis in…”
Get full text

Familial aggregation of sarcoidosis: A case-control etiologic study of sarcoidosis (ACCESS) by RYBICKI, Benjamin A, IANNUZZI, Michael C, DEPALO, Louis, HUNNINGHAKE, Gary, JOHNS, Carol, JUDSON, Marc A, KNATTERUD, Genell L, MCLENNAN, Geoffrey, NEWMAN, Lee S, RABIN, David L, ROSE, Cecile, TEIRSTEIN, Alvin S, FREDERICK, Margaret M, WEINBERGER, Steven E, YEAGER, Henry, CHERNIACK, Reuben, THOMPSON, Bruce W, ROSSMAN, Milton D, BRESNITZ, Eddy A, TERRIN, Michael L, MOLLER, David R, BARNARD, Juliana, BAUGHMAN, Robert P

“…Despite reports of familial clustering of sarcoidosis, little empirical evidence exists that disease risk in family members of sarcoidosis cases is greater…”
Get full text

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy by Simoons, M L, Maggioni, A P, Knatterud, G, Leimberger, J D, de Jaegere, P, van Domburg, R, Boersma, E, Franzosi, M G, Califf, R, Schröder, R

“…Thrombolytic therapy improves outcome in patients with myocardial infarction but is associated with an increased risk of intracranial haemorrhage. For some…”
Get more information

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial by HOOGWERF, B. J, WANESS, A, KNATTERUD, G. L, WHITE, C, CRESSMAN, M, CANNER, J, CAMPEAU, L, DOMANSKI, M, GELLER, N, HERD, A, HICKEY, A, HUNNINGHAKE, D. B

“…Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary…”
Get full text

Mental stress-induced Ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study by SHEPS, David S, MCMAHON, Robert P, RACZYNSKI, James M, LIGHT, Kathleen, KRANTZ, David S, STONE, Peter H, KNATTERUD, Genell L, KAUFMANN, Peter G, BECKER, Lewis, CARNEY, Robert M, FREEDLAND, Kenneth E, COHEN, Jerome D, SHEFFIELD, David, GOLDBERG, A. David, KETTERER, Mark W, PEPINE, Carl J

“…Ischemia during laboratory mental stress tests has been linked to significantly higher rates of adverse cardiac events. Previous studies have not been designed…”
Get full text

Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge by CHESEBRO, J. H, KNATTERUD, G, MARKIS, J. E, MUELLER, H, PASSAMANI, E. R, POWERS, E. R, RAO, A. K, ROBERTSON, T, ROSS, A, RYAN, T. J, SOBEL, B. E, WILLERSON, J, ROBERTS, R, WILLIAMS, D. O, ZARET, B. L, BRAUNWALD, E, BORER, J, COHEN, L. S, DALEN, J, DODGE, H. T, FRANCIS, C. K, HILLIS, D, LUDBROOK, P

“…Intravenous administration of 80 mg of recombinant tissue plasminogen activator (rt-PA, 40, 20, and 20 mg in successive hours) and streptokinase (SK, 1.5…”
Get full text

Long-term effects on Clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft Trial by KNATTERUD, G. L, ROSENBERG, Y, HOOGWERF, B. J, TERRIN, M. L, WHITE, C, CAMPEAU, L, GELLER, N. L, HUNNINGHAKE, D. B, FORMAN, S. A, FORRESTER, J. S, GOBEL, F. L, HERD, J. A, HICKEY, A

“…Background —The Post Coronary Artery Bypass Graft Trial, designed to compare the effects of 2 lipid-lowering regimens and low-dose anticoagulation versus…”
Get full text

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial by Gore, J M, Sloan, M, Price, T R, Randall, A M, Bovill, E, Collen, D, Forman, S, Knatterud, G L, Sopko, G, Terrin, M L

“…In the Thrombolysis in Myocardial Infarction, Phase II pilot and clinical trial, 908 patients [326 (35.9%) in the pilot study and 582 (64.0%) in the randomized…”
Get full text

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study by Roberts, R, Rogers, W J, Mueller, H S, Lambrew, C T, Diver, D J, Smith, H C, Willerson, J T, Knatterud, G L, Forman, S, Passamani, E

“…In the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial, patients received intravenous recombinant tissue-type plasminogen activator (rt-PA) and…”
Get full text

Comparison of Preoperative Characteristics of Men and Women Undergoing Coronary Artery Bypass Grafting (The Post Coronary Artery Bypass Graft [CABG] Biobehavioral Study) by Czajkowski, Susan M, Terrin, Michael, Lindquist, Ruth, Hoogwerf, Byron, Dupuis, Gilles, Shumaker, Sally A, Gray, J.Richard, Herd, J.Alan, Treat-Jacobson, Diane, Zyzanski, Steven, Knatterud, Genell L

“…A cohort of 759 coronary artery bypass grafting (CABG) patients (269 women and 490 men) was enrolled in the prospective POST CABG Biobehavioral Study at 5…”
Get full text

Early Risks of Hormone Therapy in Patients With Coronary Heart Disease by Fontanarosa, Phil B, Wenger, Nanette K, Knatterud, Genell L, Canner, Paul L

Get full text

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials by Armitage, Jane, Baigent, Colin, Barnes, Elizabeth, Betteridge, D John, Blackwell, Lisa, Blazing, Michael, Bowman, Louise, Braunwald, Eugene, Byington, Robert, Cannon, Christopher, Clearfield, Michael, Colhoun, Helen, Collins, Rory, Dahlöf, Björn, Davies, Kelly, Davis, Barry, de Lemos, James, Downs, John R, Durrington, Paul, Emberson, Jonathan, Fellström, Bengt, Flather, Marcus, Ford, Ian, Franzosi, Maria Grazia, Fulcher, Jordan, Fuller, John, Furberg, Curt, Gordon, David, Goto, Shinya, Gotto, Antonio, Halls, Heather, Harper, Charlie, Hawkins, C Morton, Herrington, Will, Hitman, Graham, Holdaas, Hallvard, Holland, Lisa, Jardine, Alan, Jukema, J Wouter, Kastelein, John, Kean, Sharon, Keech, Anthony, Kirby, Adrienne, Kjekshus, John, Knatterud (deceased), Genell, Knopp (deceased), Robert, Koenig, Wolfgang, Koren, Michael, Krane, Vera, Landray, Martin J, LaRosa, John, Lonn, Eva, MacFarlane, Peter, MacMahon, Stephen, Maggioni, Aldo, Marchioli, Roberto, Marschner, Ian, Mihaylova, Borislava, Moyé, Lemuel, Murphy, Sabina, Nakamura, Haruo, Neil, Andrew, Newman, Connie, O'Connell, Rachel, Packard, Chris, Parish, Sarah, Pedersen, Terje, Peto, Richard, Pfeffer, Marc, Poulter, Neil, Preiss, David, Reith, Christina, Ridker, Paul, Robertson, Michele, Sacks, Frank, Sattar, Naveed, Schmieder, Roland, Serruys, Patrick, Sever, Peter, Shaw, John, Shear, Charles, Simes, John, Sleight, Peter, Spata, Enti, Tavazzi, Luigi, Tobert, Jonathan, Tognoni, Gianni, Tonkin, Andrew, Trompet, Stella, Varigos, John, Wanner, Christoph, Wedel, Hans, White, Harvey, Wikstrand, John, Wilhelmsen, Lars, Wilson, Kate, Young, Robin, Yusuf, Salim, Zannad, Faiez

“…Statin therapy has been shown to reduce major vascular events and vascular mortality in a wide range of individuals, but there is uncertainty about its…”
Get full text

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience by Sloan, M A, Price, T R, Petito, C K, Randall, A M, Solomon, R E, Terrin, M L, Gore, J, Collen, D, Kleiman, N, Feit, F

“…Parenchymatous intracerebral hemorrhage (ICH) is a serious, infrequent complication of thrombolytic therapy for acute myocardial infarction. We studied the…”
Get full text

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase by Rao, A.Koneti, Pratt, Craig, Berke, Andrew, Jaffe, Allan, Ockene, Ira, Schreiber, Theodore L, Bell, William R, Knatterud, Genell, Robertson, Thomas L, Terrin, Michael L

“…Two hundred ninety patients with acute myocardial infarction were treated according to random assignment with an intravenous infusion of either 80 mg of…”
Get full text

Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study by Stone, P.H., Thompson, B., Zaret, B.L., Chaitman, B., Gibson, R.S., Schweiger, M.J., Steingart, R., Kirshenbaum, J., Thompson, C., Fung, A., McCabe, C.H., Knatterud, G.L., Braunwald, E.

“…Context Current management of patients with unstable angina and non-Q wave myocardial infarction generally consists of intensive medical therapy, with…”
Get full text

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials by Fulcher, Jordan, O'Connell, Rachel, Voysey, Merryn, Emberson, Jonathan, Blackwell, Lisa, Mihaylova, Borislava, Simes, John, Collins, Rory, Kirby, Adrienne, Colhoun, Helen, Braunwald, Eugene, La Rosa, John, Pedersen, T R, Tonkin, Andrew, Davis, Barry, Sleight, Peter, Franzosi, Maria Grazia, Baigent, Colin, Keech, Anthony

“…Summary Background Whether statin therapy is as effective in women as in men is debated, especially for primary prevention. We undertook a meta-analysis of…”
Get full text